# Can you eat too much protein?

"Too much protein" is not a single threshold. The main concerns are (1) kidney outcomes (especially in people with reduced kidney function), (2) long-term cardiometabolic and mortality outcomes (often discussed via IGF-1/mTOR signaling hypotheses), and (3) diminishing returns for muscle gain once intake is already high. ([Devries et al., 2018](https://doi.org/10.1093/jn/nxy197); [Remer et al., 2023](https://doi.org/10.1007/s00394-023-03143-7); [Naghshi et al., 2020](https://doi.org/10.1136/bmj.m2412); [Morton et al., 2018](https://doi.org/10.1136/bjsports-2017-097608))

## What "high protein" means in the studies

A systematic review/meta-analysis of randomized trials in adults without kidney disease defined "higher-protein" diets as ≥1.5 g/kg/day, ≥20% of energy from protein, or ≥100 g/day, compared with normal- or lower-protein diets. ([Devries et al., 2018](https://doi.org/10.1093/jn/nxy197))

An umbrella review of systematic reviews evaluating kidney-related outcomes framed "higher protein intake" as intakes above commonly recommended levels (often operationalized as >0.8 g/kg/day in the underlying reviews). Decades-long exposure data are scarce. ([Remer et al., 2023](https://doi.org/10.1007/s00394-023-03143-7))

Very high intakes (>2 g/kg/day) appear most often in sports/athlete trials. In general-population observational cohorts, "high protein" is often closer to ~1 g/kg/day and operationalized by intake quantiles rather than athlete-level targets. ([Antonio et al., 2016](https://doi.org/10.1155/2016/9104792); [Jhee et al., 2020](https://doi.org/10.1093/ndt/gfz115))

## Claim 1: "High protein (>2 g/kg) damages kidneys over time"

### What the best trial evidence in healthy adults actually shows

In a meta-analysis of 28 randomized controlled trials in adults without kidney disease, higher-protein diets produced a slightly higher post-intervention GFR in "post-only" comparisons, but did not differ from lower/normal protein diets for change in GFR from baseline (i.e., no signal of declining filtration over the trial periods studied). ([Devries et al., 2018](https://doi.org/10.1093/jn/nxy197))

That meta-analysis interpreted the higher post-intervention GFR as a physiological response to dietary protein, not evidence of damage. It noted limitations including unclear selection bias risk in the included trials. ([Devries et al., 2018](https://doi.org/10.1093/jn/nxy197))

A controlled feeding trial (OmniHeart) comparing higher-protein vs higher-carbohydrate dietary patterns reported increases in estimated GFR with higher protein intake. This supports the idea that protein can raise filtration markers in the short term rather than immediately "damage" kidneys in the clinical sense. ([Juraschek et al., 2013](https://doi.org/10.1053/j.ajkd.2012.10.017))

### Evidence at "very high" intakes

A 1-year crossover study in resistance-trained men testing a very high-protein diet reported no harmful changes in measured health indices, including renal-related labs. Participants' "normal" intake was already very high, so this trial is best interpreted as "very high vs even higher" protein in trained men, rather than moderate vs very high. ([Antonio et al., 2016](https://doi.org/10.1155/2016/9104792))

This supports a narrower conclusion: in selected healthy, resistance-trained adults, very high protein intakes over ~1 year have not consistently shown kidney harm on standard lab markers. The question of longer-term effects and broader generalizability remains open. ([Antonio et al., 2016](https://doi.org/10.1155/2016/9104792); [Remer et al., 2023](https://doi.org/10.1007/s00394-023-03143-7))

### What long-term evidence says (and does not say)

An umbrella review of systematic reviews concluded that, across reviewed kidney-related outcomes (CKD, stones, albuminuria, GFR, and related parameters), the observed changes with higher protein intake generally looked physiological/regulatory rather than clearly pathologic. It did not find convincing evidence that higher protein intake above recommendations causes clinically meaningful kidney disease outcomes or kidney stones. It did stress that long-term data "over decades" are still needed. ([Remer et al., 2023](https://doi.org/10.1007/s00394-023-03143-7))

A systematic review/meta-analysis of observational studies summarizing cohort evidence on incident CKD reported that higher protein intake was not associated with higher CKD risk overall (and in pooled results was in the protective direction). The results had substantial heterogeneity, and causal interpretation from dietary questionnaires is difficult. ([Cheng et al., 2024](https://doi.org/10.3389/fnut.2024.1408424))

**Bottom line for this claim:** The strongest randomized evidence in adults without kidney disease does not show that higher-protein diets cause a decline in GFR over typical trial durations, though they may increase measured filtration. ([Devries et al., 2018](https://doi.org/10.1093/jn/nxy197)) The evidence base is still weaker than people assume for multi-decade exposure, which is why "no evidence of harm in trials" is not the same as "proven harmless forever." ([Remer et al., 2023](https://doi.org/10.1007/s00394-023-03143-7))

## Claim 2: "High protein is only a concern for those with pre-existing kidney disease"

This statement is closer to what the evidence suggests, but it is still an oversimplification.

In the Nurses' Health Study analysis, higher protein intake was not associated with renal function decline among women with normal baseline kidney function, but was associated with faster decline among those with mild renal insufficiency, particularly for non-dairy animal protein. ([Knight et al., 2003](https://doi.org/10.7326/0003-4819-138-6-200303180-00009))

In a community-based prospective cohort (n=9,226, Korean adults), higher protein intake in the setting of renal hyperfiltration was associated with a more rapid decline in kidney function over follow-up. Baseline renal physiology (hyperfiltration status) may modify risk. The highest protein quartile in this cohort consumed 1.7 ± 0.6 g/kg/day, and the lowest consumed 0.6 ± 0.1 g/kg/day. ([Jhee et al., 2020](https://doi.org/10.1093/ndt/gfz115))

These cohort findings are consistent with a "susceptibility" model: higher protein intake may be largely tolerated in people with healthy kidneys, but could be more concerning in those with reduced reserve (mild insufficiency) or specific phenotypes (hyperfiltration). ([Knight et al., 2003](https://doi.org/10.7326/0003-4819-138-6-200303180-00009); [Jhee et al., 2020](https://doi.org/10.1093/ndt/gfz115))

Trial evidence in adults without kidney disease does not show declines in GFR with higher-protein diets (and thus does not support blanket fear in healthy people), which is part of why most concerns focus on people with impaired kidney function or higher baseline risk. ([Devries et al., 2018](https://doi.org/10.1093/jn/nxy197); [Remer et al., 2023](https://doi.org/10.1007/s00394-023-03143-7))

## Kidney stones are related, but not identical, to "kidney damage"

A systematic review and dose-response meta-analysis of prospective cohorts found that higher intake of non-dairy animal protein and certain meat categories (e.g., processed meat; red meat dose increments) was associated with higher kidney stone risk, while higher dairy protein intake was associated with a lower risk. The authors rated credibility for many exposures as low. ([Asoudeh et al., 2022](https://doi.org/10.1093/advances/nmac013))

In contrast, an umbrella review of systematic reviews graded the overall certainty as "possible" that stone risk is not associated with higher protein intake above recommendations. It again noted that longer-term data are needed and that many kidney function-related parameters increase physiologically with higher protein. ([Remer et al., 2023](https://doi.org/10.1007/s00394-023-03143-7))

Protein source and dietary context (e.g., animal vs dairy vs plant patterns, accompanying sodium/acid load, hydration) may matter as much as "total grams." Stone outcomes remain an area where observational evidence and review-level conclusions can differ depending on how "high protein" is operationalized. ([Asoudeh et al., 2022](https://doi.org/10.1093/advances/nmac013); [Remer et al., 2023](https://doi.org/10.1007/s00394-023-03143-7))

## Claim 3: "Excess protein may accelerate aging through mTOR activation"

### What is supported in humans (biomarkers and outcomes)

A systematic review/meta-analysis in humans found that increasing dietary protein intake is associated with higher circulating IGF-1 (standardized mean difference 0.4, 95% CI 0.18-0.61, p < 0.001). ([Kazemi et al., 2020](https://doi.org/10.1016/j.clnu.2019.07.030)) IGF-1 signaling is one of the nutrient/hormone pathways discussed in the context of mTOR-related aging hypotheses.

In a cohort analysis of adults aged 50 and over (NHANES III, n=6,381), lower protein intake was associated with lower IGF-1 and lower cancer and all-cause mortality in the 50-65 age group, but not in those 66 and older. Age may modify the relationship between protein-related endocrine signals and health outcomes. ([Levine et al., 2014](https://doi.org/10.1016/j.cmet.2014.02.006))

However, when zooming out to larger evidence syntheses of long-term outcomes, a systematic review/meta-analysis of prospective cohorts found higher total protein intake was associated with a modestly lower all-cause mortality risk, and plant protein intake was associated with lower all-cause and cardiovascular mortality. Animal protein was not significantly associated with cardiovascular or cancer mortality in that synthesis. ([Naghshi et al., 2020](https://doi.org/10.1136/bmj.m2412))

In the Nurses' Health Study, higher midlife protein intake, especially plant protein, was associated with higher odds of "healthy aging" (a composite including freedom from major chronic disease plus maintained physical and cognitive function). ([Korat et al., 2024](https://doi.org/10.1016/j.ajcnut.2023.11.010))

### What this means for the "mTOR speeds aging" narrative

In summary: higher protein intake can shift endocrine markers like IGF-1 upward in humans, but long-term human outcome data do not cleanly support a universal claim that "more protein accelerates aging." Associations appear to vary by age and protein source (plant vs animal). ([Kazemi et al., 2020](https://doi.org/10.1016/j.clnu.2019.07.030); [Levine et al., 2014](https://doi.org/10.1016/j.cmet.2014.02.006); [Naghshi et al., 2020](https://doi.org/10.1136/bmj.m2412); [Korat et al., 2024](https://doi.org/10.1016/j.ajcnut.2023.11.010))

## Claim 4: "There's a ceiling effect for muscle-building benefit"

A systematic review/meta-analysis/meta-regression of 49 resistance-training RCTs found that protein supplementation increased gains in strength and fat-free mass overall, but that total daily protein intakes above ~1.62 g/kg/day did not further increase resistance-training-induced gains in fat-free mass in their breakpoint analysis. ([Morton et al., 2018](https://doi.org/10.1136/bjsports-2017-097608))

That breakpoint estimate had a reported 95% confidence interval extending roughly from ~1.03 to ~2.20 g/kg/day. There is meaningful individual variability and uncertainty in where diminishing returns begin. The breakpoint model itself was not statistically significant in their report, reinforcing that this is not a hard "line." ([Morton et al., 2018](https://doi.org/10.1136/bjsports-2017-097608))

So the "ceiling" claim is broadly supported for average hypertrophy outcomes in RCTs, but it is better described as diminishing returns rather than a hard cutoff. It speaks to muscle gain, not necessarily other reasons people might choose higher protein (e.g., appetite/energy restriction contexts, which require separate evidence). ([Morton et al., 2018](https://doi.org/10.1136/bjsports-2017-097608))

## Quick reference points (from higher-quality evidence)

* Higher-protein diets in kidney RCT meta-analysis were typically ≥1.5 g/kg/day or ≥20% energy from protein (among other operational definitions). ([Devries et al., 2018](https://doi.org/10.1093/jn/nxy197))
* In healthy adults, higher-protein diets increased post-intervention GFR slightly, but did not differ for change in GFR from baseline vs lower/normal protein diets. ([Devries et al., 2018](https://doi.org/10.1093/jn/nxy197))
* An umbrella review found no convincing evidence that higher protein intake above recommendations causes clinically meaningful kidney disease or kidney stone outcomes. Decades-long data are still needed. ([Remer et al., 2023](https://doi.org/10.1007/s00394-023-03143-7))
* In a 1-year crossover study in resistance-trained men (with already very high baseline protein intake), even higher protein intake did not produce harmful changes in renal-related lab markers. ([Antonio et al., 2016](https://doi.org/10.1155/2016/9104792))
* In cohorts, higher protein intake may be linked to faster renal decline in higher-risk subgroups (mild insufficiency; hyperfiltration phenotype). ([Knight et al., 2003](https://doi.org/10.7326/0003-4819-138-6-200303180-00009); [Jhee et al., 2020](https://doi.org/10.1093/ndt/gfz115))
* Increasing protein intake raises circulating IGF-1 in a human systematic review/meta-analysis. ([Kazemi et al., 2020](https://doi.org/10.1016/j.clnu.2019.07.030))
* Long-term cohort meta-analysis shows plant protein is associated with lower all-cause and CVD mortality, while total protein is modestly inversely associated with all-cause mortality. ([Naghshi et al., 2020](https://doi.org/10.1136/bmj.m2412))
* Midlife plant protein intake is strongly associated with "healthy aging" odds in a large prospective cohort. ([Korat et al., 2024](https://doi.org/10.1016/j.ajcnut.2023.11.010))
* For hypertrophy in resistance-training RCTs, gains plateau on average around ~1.6 g/kg/day in breakpoint modeling, but uncertainty plausibly extends into the low-2 g/kg/day range for some individuals (i.e., diminishing returns, not a sharp cutoff). ([Morton et al., 2018](https://doi.org/10.1136/bjsports-2017-097608))

## Practical interpretation

* If you already have reduced kidney function (even "mild" insufficiency), observational evidence suggests higher total protein, and particularly non-dairy animal protein, may be associated with faster decline, so "more is always better" is not a safe assumption. ([Knight et al., 2003](https://doi.org/10.7326/0003-4819-138-6-200303180-00009))
* If you have evidence of renal hyperfiltration (or you're in a higher-risk phenotype), cohort evidence links higher protein intake to more rapid eGFR decline, which supports individualized caution. ([Jhee et al., 2020](https://doi.org/10.1093/ndt/gfz115))
* If you are an adult without known kidney disease, randomized evidence does not show declining GFR with higher-protein diets (though filtration markers can rise), and reviews conclude there is no convincing signal that higher protein intake above recommendations causes clinically meaningful kidney disease outcomes. The lack of decades-long randomized data is a real gap. ([Devries et al., 2018](https://doi.org/10.1093/jn/nxy197); [Remer et al., 2023](https://doi.org/10.1007/s00394-023-03143-7))
* For muscle gain, the best RCT synthesis suggests diminishing returns around ~1.6 g/kg/day on average, with uncertainty that plausibly extends into the low-2 g/kg/day range for some individuals. ([Morton et al., 2018](https://doi.org/10.1136/bjsports-2017-097608))
* For "aging via mTOR" concerns, the most human-relevant evidence shows protein can raise IGF-1, but long-term cohort syntheses do not support a universal "more protein = shorter life" conclusion. Plant protein is consistently the more favorable direction in pooled mortality evidence and healthy-aging outcomes. ([Kazemi et al., 2020](https://doi.org/10.1016/j.clnu.2019.07.030); [Naghshi et al., 2020](https://doi.org/10.1136/bmj.m2412); [Korat et al., 2024](https://doi.org/10.1016/j.ajcnut.2023.11.010); [Levine et al., 2014](https://doi.org/10.1016/j.cmet.2014.02.006))

## References

* Devries MC, Sithamparapillai A, Brimble KS, Banfield L, Morton RW, Phillips SM. Changes in Kidney Function Do Not Differ between Healthy Adults Consuming Higher- Compared with Lower- or Normal-Protein Diets: A Systematic Review and Meta-Analysis. *J Nutr.* 2018;148(11):1760-1775. DOI: 10.1093/jn/nxy197.
* Remer T, Kalotai N, Amini AM, et al. Protein intake and risk of urolithiasis and kidney diseases: an umbrella review of systematic reviews for the evidence-based guideline of the German Nutrition Society. *Eur J Nutr.* 2023;62(5):1957-1975. DOI: 10.1007/s00394-023-03143-7.
* Antonio J, Ellerbroek A, Silver T, Vargas L, Tamayo A, Buehn R, Peacock CA. A High Protein Diet Has No Harmful Effects: A One-Year Crossover Study in Resistance-Trained Males. *J Nutr Metab.* 2016;2016:9104792. DOI: 10.1155/2016/9104792.
* Juraschek SP, Appel LJ, Anderson CA, Miller ER 3rd. Effect of a high-protein diet on kidney function in healthy adults: results from the OmniHeart trial. *Am J Kidney Dis.* 2013;61(4):547-554. DOI: 10.1053/j.ajkd.2012.10.017.
* Knight EL, Stampfer MJ, Hankinson SE, Spiegelman D, Curhan GC. The Impact of Protein Intake on Renal Function Decline in Women with Normal Renal Function or Mild Renal Insufficiency. *Ann Intern Med.* 2003;138(6):460-467. DOI: 10.7326/0003-4819-138-6-200303180-00009.
* Jhee JH, Kee YK, Park S, et al. High-protein diet with renal hyperfiltration is associated with rapid decline rate of renal function: a community-based prospective cohort study. *Nephrol Dial Transplant.* 2020;35(1):98-106. DOI: 10.1093/ndt/gfz115.
* Cheng Y, Zheng G, Song Z, Zhang G, Rao X, Zeng T. Dietary protein intake and risk of chronic kidney disease: a systematic review and meta-analysis. *Front Nutr.* 2024;11:1408424. DOI: 10.3389/fnut.2024.1408424.
* Asoudeh F, Talebi S, Jayedi A, et al. Associations of Total Protein or Animal Protein Intake and Animal Protein Sources with Risk of Kidney Stones: A Systematic Review and Dose–Response Meta-Analysis. *Adv Nutr.* 2022;13(3):821-832. DOI: 10.1093/advances/nmac013.
* Kazemi A, Speakman JR, Soltani S, Djafarian K. Effect of calorie restriction or protein intake on circulating levels of insulin like growth factor I in humans: A systematic review and meta-analysis. *Clin Nutr.* 2020;39(6):1705-1716. DOI: 10.1016/j.clnu.2019.07.030.
* Levine ME, Suarez JA, Brandhorst S, et al. Low Protein Intake Is Associated with a Major Reduction in IGF-1, Cancer, and Overall Mortality in the 65 and Younger but Not Older Population. *Cell Metab.* 2014;19(3):407-417. DOI: 10.1016/j.cmet.2014.02.006.
* Naghshi S, Sadeghi O, Willett WC, Esmaillzadeh A. Dietary intake of total, animal, and plant proteins and risk of all cause, cardiovascular, and cancer mortality: systematic review and dose-response meta-analysis of prospective cohort studies. *BMJ.* 2020;370:m2412. DOI: 10.1136/bmj.m2412.
* Korat AVA, Shea MK, Jacques PF, et al. Dietary protein intake in midlife in relation to healthy aging – results from the prospective Nurses' Health Study cohort. *Am J Clin Nutr.* 2024;119(2):271-282. DOI: 10.1016/j.ajcnut.2023.11.010.
* Morton RW, Murphy KT, McKellar SR, et al. A systematic review, meta-analysis and meta-regression of the effect of protein supplementation on resistance training-induced gains in muscle mass and strength in healthy adults. *Br J Sports Med.* 2018;52(6):376-384. DOI: 10.1136/bjsports-2017-097608.
